Articles From: CubeSmart Reports Second Quarter 2014 Results: FFO Per Share Grows 17.4%; Same-Store NOI Increases 9.7% to CUI Global Reports Unaudited Second Quarter 2014 Financial Results


http://media.marketwire.com/attachments/201302/130232_logo-R-red-on-white.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136388&ProfileId=051205&sourceType=1 MALVERN, PA --
Sign-up for CubeSmart Reports Second Quarter 2014 Results: FFO Per Share Grows 17.4%; Same-Store NOI Increases 9.7% investment picks
http://media.marketwire.com/attachments/201302/130232_logo-R-red-on-white.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147248&ProfileId=051205&sourceType=1 MALVERN, PA --
Sign-up for CubeSmart's Credit Rating Upgraded to Baa2 by Moody's Investors Service investment picks
SAN DIEGO, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Corporation (NYSE:CUB) announced today the following appointments aimed at strengthening its defense business unit worldwide.
Sign-up for Cubic Appoints Mike Knowles and Mike Twyman to Key Defense Business Segment Roles investment picks
SAN DIEGO, Calif., Aug.
Sign-up for Cubic Awarded $1.8 Million Contract to Supply Common Data Link for Small Unmanned Aircraft Systems investment picks
SAN DIEGO, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Corporation (NYSE: CUB) announced today that it was awarded a new order valued at $4.1 million for its Instrumentable Multiple Integrated Laser Engagement Tactical Vehicle Systems (I-MILES TVS) from the U.S. Army's Program Executive Office for Simulation, Training and Instrumentation (PEO STRI). The order is exercised under Option III under the indefinite delivery/indefinite quantity (ID/IQ) contract awarded in 2010.
Sign-up for Cubic Awarded $4.1 Million Training Order for U.S. Army investment picks
SAN DIEGO, Calif., Aug.
Sign-up for Cubic Awarded $57 Million Contract to Support the Korea Battle Simulation Center for the U.S. Army investment picks
SAN DIEGO, Calif., Aug.
Sign-up for Cubic Awarded Major New Contract to Supply Army Mobile Instrumented Training System investment picks
Cubic Corporation (NYSE: CUB) announced today that its Board of Directors has approved a regular semiannual dividend of 12 cents per share, payable on August 25, 2014, to shareholders of record on August 11, 2014.
Sign-up for Cubic Corporation Announces Semiannual Dividend investment picks
SAN DIEGO, Calif., Aug.
Sign-up for Cubic Corporation Names Suzanne Hatcher as Director of Corporate Communications investment picks
SAN DIEGO, Calif., July 3, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Applications, Inc. (CAI), a wholly –owned subsidiary of Cubic Corporation (NYSE: CUB) announced today that it has received a contract modification worth more than $60 million.
Sign-up for Cubic Corporation Receives $60 Million Modification U.S. Army Joint Readiness Training Center Mission Support Contract investment picks
Cubic Corporation (NYSE: CUB) plans to hold a conference call on Monday, August 4, 2014 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its financial results for the quarter ended June 30, 2014.
Sign-up for Cubic Corporation to Announce Third Quarter 2014 Results and Host Conference Call on August 4, 2014 investment picks
SAN DIEGO, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Corporation (NYSE:CUB) announced that effective July 1, Bill Toti will succeed Jimmie Balentine as president of Cubic's Mission Support Services segment.
Sign-up for Cubic Names Bill Toti as New President of Mission Support Services investment picks
Cubic Corporation (NYSE:CUB) today reported its financial results for the quarter and nine-month periods ended June 30, 2014.
Sign-up for Cubic Reports Third Quarter Fiscal Year 2014 Results and Lowers 2014 Revenue and EPS Guidance investment picks
Cubic Corporation (NYSE: CUB) today announced it will participate in the 5 th Annual Credit Suisse Mid & Small Cap Conference in New York City on Wednesday, Sept.
Sign-up for Cubic to Participate in Credit Suisse Mid & Small Cap Conference investment picks
SAN DIEGO, Calif., June 27, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Cubic Defense Systems , a Business Segment of Cubic Corporation (NYSE: CUB) announced today it was awarded a new contract valued at more than $12 million to provide specialist Home Station Counter IED training and an Instrumented Collective Combat Training Centre with follow on maintenance to increase full spectrum training capacity for the Italian Army.
Sign-up for Cubic Wins $12 Million Italian Army Contract for Home Station Training investment picks
2014/9/18
With resistant bacterial infections resulting in an estimated 25,000 deaths in the European Union and 23,000 deaths in the United States annually, the issues of rising antibiotic resistance and the lack of treatment options have raised alarms with world leaders.
Sign-up for Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the European Medicines Agency (EMA) has accepted for review the Company’s Marketing Authorization Application (MAA) for its investigational antibiotic ceftolozane/tazobactam. Cubist is seeking approval of ceftolozane/tazobactam for the treatment of complicated urinary tract Infections and complicated intra-abdominal infections, with a decision from the European Commission (EC) expected during the second half of 2015.
Sign-up for Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling nine lots of CUBICIN® (daptomycin for injection) to the user level following complaints of foreign particulate matter in reconstituted vials.
Sign-up for Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Nine Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Following Complaints of Foreign Particulate Matter in Reconstituted Vials investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling certain lots of CUBICIN® (daptomycin for injection) to the user level due to the potential presence of glass particulate matter in vials produced by a contract manufacturer.
Sign-up for Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2014.
Sign-up for Cubist Reports Second Quarter 2014 Financial Results investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its second quarter 2014 financial results at 4:00 p.m. ET on Tuesday, July 22, 2014.
Sign-up for Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2013.
Sign-up for Cubist to Present at August Investor Conference investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Mike Bonney, Cubist’s CEO, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, to discuss the company’s business activities, financial outlook, and current news.
Sign-up for Cubist to Present at Morgan Stanley Global Healthcare Conference investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data at the 54 th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9 in Washington, D.C. Data highlighted will offer insights into Cubist’s commitment to identifying treatments for drug-resistant Gram-positive and Gram-negative bacteria that cause serious infections.
Sign-up for Cubist to Present New Data from Antibiotics Portfolio at 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it will present new data from a phase 1 safety and pharmacokinetic study of fidaxomicin in children with Clostridium difficile- associated diarrhea (CDAD) at IDWeek 2014, being held October 8-12 in Philadelphia.
Sign-up for Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data from its antibiotics portfolio at IDWeek 2014, October 8-12, in Philadelphia, PA.
Sign-up for Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014 investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announces SIVEXTRO ™ (tedizolid phosphate) indicated for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI) is now available in the U.S. in once-daily I.V. and oral formulations.
Sign-up for Cubist’s Once-daily SIVEXTRO™ (tedizolid phosphate) Available for Physician and Hospital Order in I.V. and Oral Formulations investment picks
2014/8/1
CUC Announces Second Quarter Results for the Period Ended June 30, 2014 Canada NewsWire Caribbean Utilities Company, Ltd.
Sign-up for CUC Announces Second Quarter Results for the Period Ended June 30, 2014 investment picks
TUALATIN, Ore.
Sign-up for CUI Global Reports Unaudited Second Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CubeSmart Reports Second Quarter 2014 Results: FFO Per Share Grows 17.4%; Same-Store NOI Increases 9.7% to CUI Global Reports Unaudited Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices